Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy

Journal of Gene Medicine

Volumn 10, Issue 4, 2008, Pages 421-429

  Jin, Xu ^a   Mei, Lin ^a,d   Song, Cunxian ^a   Liu, Lanxia ^a   Leng, Xigang ^a   Sun, Hongfan ^a   Kong, Deling ^b   Levy, Robert J ^c  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b NANKAI UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Nonviral vector; Plasmid DNA; Site specific gene delivery; Stent

Indexed keywords

DNA ANTIBODY; ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN M ANTIBODY; PLASMID DNA; PROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CORONARY STENT; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; INTIMA; MOLECULAR STABILITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; REPORTER GENE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CORONARY VESSELS; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; IMMUNOGLOBULIN M; IODINE RADIOISOTOPES; MALE; MICE; PLASMIDS; RABBITS; STENTS;

ORYCTOLAGUS CUNICULUS;

EID: 42049093073     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1165     Document Type: Article

References (50)

1. Sharif F, Daly K, Crowley J, et al. Current status of catheter- and stent-based gene therapy. Cardiovasc Res 2004; 64: 208-216.
2. Bennett MR, O'Sullivan M. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Pharmacol Ther 2001; 91: 149-166.
3. Bauters C, Isner JM. The biology of restenosis. Prog Cardiovasc Dis 1997; 40: 107-116.
4. Rutanen J, Markkanen J, Yla-Herttuala S. Gene therapy for restenosis: current status. Drugs 2002; 62: 1575-1585.
5. Kullo IJ, Simari RD, Schwartz RS. Vascular gene transfer: from bench to bedside. Arterioscler Thromb Vasc Biol 1999; 19: 196-207.
6. Kopp CW, Martin RD. Gene therapy approaches for the prevention of restenosis. Curr Vasc Pharmacol 2004; 2: 183-189.
7. Walter DH, Cejna M, Diaz-Sandoval L, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004; 110: 36-45.
8. Laitinen M, Zachary I, Breier G, et al. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997; 8: 1737-1744.
9. Turunen MP, Hiltunen MO, Ruponen M, et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther 1999; 6: 6-11.
10. Laitinen M, Hartikainen J, Hiltunen MO, et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11: 263-270.
11. Numaguchi Y, Okumura K, Harada M, et al. Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries. Cardiovasc Res 2004; 61: 177-185.
12. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-1239.
13. Morishita R, Gibbons GH, Kaneda Y, et al. Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension 1993; 21: 894-899.
14. Kaneda Y, Nakajima T, Nishikawa T, et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002; 6: 219-226.
15. Tirlapur UK, Konig K. Targeted transfection by femtosecond laser. Nature 2002; 418: 290-291.
16. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995; 2: 710-722.
17. Thierry AR, Lunardi-Iskandar Y, Bryant JL, et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA 1995; 92: 9742-9746.
18. Xu Y, Szoka JF. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996;35: 5616-5623.
19. Liu Y, Mounkes LC, Liggitt HD, et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 1997; 15: 167-173.
20. Liu F, Qi H, Huang L, et al. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 1997; 4: 517-523.
21. Burton DY, Song C, Fishbein I, et al. The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Hum Gene Ther 2003; 14: 907-922.
22. Mizuguchi H, Hayakawa T. Targeted adenovirus vectors. Hum Gene Ther 2004; 15: 1034-1044.
23. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000; 18: 1181-1184.
24. KJugherz BD, Song C, DeFelice S, et al. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther 2002; 13: 443-454.
25. Abrahams JM, Song C, DeFelice S, et al. Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering. Stroke 2002; 33: 1376-1382.
26. Levy RJ, Song C, Tallapragada S, et al. Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther 2001; 8: 659-667.
27. Stachelek SJ, Song C, Alferiev I, et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther 2004; 11: 15-24.
28. Mei L, An X, Song C, et al. Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med 2006; 8: 690-698.
29. Haisma HJ, Grill J, Curiel DT, et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 2000; 7: 901-904.
30. Ye YW, Landau C, Willard JE, et al. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998; 26: 398-408.
31. Takahashi A, Palmer-Opolski M, Smith RC, et al. Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent. Gene Ther 2003; 10: 1471-1478.
32. Perlstein I, Connolly JM, Cui X, et al. DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection. Gene Ther 2003; 10: 1420-1428.
33. Wu YX, Johnson T, Herdeg C, et al. Stent-based local delivery of therapeutic adenovirus effectively reduces neointimal proliferation in porcine coronaries. Di Yi Jun Yi Da Xue Xue Bao 2003; 23: 1263-1265.
34. Hussain AA, Awad R, Crooks PA, et al. Chloramine-T in radiolabeling techniques. I. Kinetics and mechanism of the reaction between chloramine-T and amino acids. Anal Biochem 1993; 214: 495-499.
35. Wheeler VC, Coutelle C. Nondegradative in vitro labeling of plasmid DNA. Anal Biochem 1995; 225: 374-376.
36. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003; 10: 1135-1141.
37. Dishart KL, Denby L, George SJ, et al. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J Mol Cell Cardiol 2003; 35: 739-748.
38. Yang X, Atalar E, Li D, et al. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 2001; 104: 1588-1590.
39. White SJ, Nicklin SA, Buning H, et al. Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation 2004; 109: 513-519.
40. Rolling F, Nong Z, Pisvin S, et al. Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 1997; 4: 757-761.
41. Yanase K, Smith RM, Puccetti A, et al. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest 1997; 100: 25-31.
42. Zack DJ, Stempniak M, Wong ML, et al. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol 1996; 157: 2082-2088.
43. Avrameas A, Gasmi L, Buttin G. DNA and heparin alter the internalization process of anti-DNA monoclonal antibodies according to patterns typical of both the charged molecule and the antibody. J Autoimmun 2001; 16: 383-391.
44. Wang K, Kessler PD, Zhou Z, et al. Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Mol Ther 2003; 7: 597-603.
45. Simons M, Edelman ER, DeKeyser JL, et al. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67-70.
46. Kataoka C, Egashira K, Ishibashi M, et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004; 286: H768-H774.
47. Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2003; 1: 393-400.
48. Kitamoto S, Egashira K, Takeshita A. Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. J Pharmacol Sci 2003; 91: 192-196.
49. Kipshidze NN, Vim HS, Iversen P, et al. Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J Am Coll Cardiol 2002; 39: 1686-1691.
50. Jeschke MG, Klein D. Liposomal gene transfer of multiple genes is more effective than gene transfer of a single gene. Gene Ther 2004; 11: 847-855.